Effects of Trophectoderm (TE) Biopsy on the Health and Development of Children Born After Preimplantation Genetic Testing (PGT) Cycles.
A Prospective Observational Study of the Impact of Blastocyst Biopsy on Postnatal Growth in Children Born After Preimplantation Genetic Testing
1 other identifier
observational
330
1 country
1
Brief Summary
This study aims to investigate the effects of trophectoderm (TE) biopsy on the health and development of children born after preimplantation genetic testing (PGT) cycles. The blastocyst biopsy is performed as part of standard clinical practice, in accordance with established protocols and current national regulations governing assisted reproduction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 18, 2025
CompletedStudy Start
First participant enrolled
December 22, 2025
CompletedFirst Posted
Study publicly available on registry
January 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 27, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 27, 2028
January 20, 2026
January 1, 2026
2.8 years
November 18, 2025
January 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Impact of Blastocyst Biopsy on Postnatal Growth at One Year
Questionnaire
12 months of life of children
Secondary Outcomes (1)
Long-Term Growth After Blastocyst Biopsy
At birth of children and at 60 months of age
Other Outcomes (1)
Exploratory Objectives: Health and development of children at the first and fifth years of life.
At 12 and at 60 months of age
Study Arms (2)
Cases
110 children born as single live births after their mothers underwent a PGT cycle followed by frozen embryo transfer (FET).
Controls
220 children born as single live births after their mothers underwent only FET.
Interventions
The only additional procedure involved in this study is the administration of a questionnaire to the parents, which is not part of routine clinical follow-up. The questionnaire was originally developed in the context of the Norwegian Mother and Child Cohort Study (MoBa).
Eligibility Criteria
The study will involve a total of 330 children born as single live births after their mothers underwent assisted reproduction technology (ART) treatment. The participant population includes: * Cases: 110 children born as single live births after their mothers underwent a PGT cycle followed by frozen embryo transfer (FET). * Controls: 220 children born as single live births after their mothers underwent only FET.
You may qualify if:
- Child: Has completed the first year of life at the time of data collection.
- Child: Does not have any pre-existing medical conditions that significantly affect growth (weight and height).
- Mother: Able to provide informed consent for participation in the study.
- Mother: Conceived between the ages of 18 and 43.
- Mother: Achieved a singleton live birth with a single gestational sac.
- Mother: Underwent a PGT cycle followed by FET.
- Child: Has completed the first year of life at the time of data collection.
- Child: Does not have any pre-existing medical conditions that significantly affect growth (weight and height).
- Mother: Able to provide informed consent for participation in the study.
- Mother: Conceived between the ages of 18 and 43.
- Mother: Achieved a singleton live birth with a single gestational sac.
- Mother: Underwent only FET.
- Participants will be excluded from this study if they meet any of the following criteria:
- Mother: Unable or unwilling to sign the informed consent.
- Mother: Has undergone a fresh embryo transfer.
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Irccs San Raffaele Hospital
Milan, Milano, 20132, Italy
Related Publications (8)
Alteri A, Campo G, Pagliardini L, Privitera L, Cavoretto PI, Candiani M, Papaleo E, Vigano P. The effect of vitrified-warmed blastocyst transfer on postnatal growth: a 1-year follow-up questionnaire study. Reprod Biomed Online. 2022 May;44(5):907-914. doi: 10.1016/j.rbmo.2021.12.018. Epub 2022 Jan 16.
PMID: 35219589BACKGROUNDAlteri A, Cermisoni GC, Pozzoni M, Gaeta G, Cavoretto PI, Vigano P. Obstetric, neonatal, and child health outcomes following embryo biopsy for preimplantation genetic testing. Hum Reprod Update. 2023 May 2;29(3):291-306. doi: 10.1093/humupd/dmad001.
PMID: 36655536BACKGROUNDvon Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014 Dec;12(12):1495-9. doi: 10.1016/j.ijsu.2014.07.013. Epub 2014 Jul 18.
PMID: 25046131BACKGROUNDHou W, Shi G, Ma Y, Liu Y, Lu M, Fan X, Sun Y. Impact of preimplantation genetic testing on obstetric and neonatal outcomes: a systematic review and meta-analysis. Fertil Steril. 2021 Oct;116(4):990-1000. doi: 10.1016/j.fertnstert.2021.06.040. Epub 2021 Aug 7.
PMID: 34373103BACKGROUNDMagnus P, Birke C, Vejrup K, Haugan A, Alsaker E, Daltveit AK, Handal M, Haugen M, Hoiseth G, Knudsen GP, Paltiel L, Schreuder P, Tambs K, Vold L, Stoltenberg C. Cohort Profile Update: The Norwegian Mother and Child Cohort Study (MoBa). Int J Epidemiol. 2016 Apr;45(2):382-8. doi: 10.1093/ije/dyw029. Epub 2016 Apr 10.
PMID: 27063603BACKGROUNDOng YY, Sadananthan SA, Aris IM, Tint MT, Yuan WL, Huang JY, Chan YH, Ng S, Loy SL, Velan SS, Fortier MV, Godfrey KM, Shek L, Tan KH, Gluckman PD, Yap F, Choo JTL, Ling LH, Tan K, Chen L, Karnani N, Chong YS, Eriksson JG, Wlodek ME, Chan SY, Lee YS, Michael N. Mismatch between poor fetal growth and rapid postnatal weight gain in the first 2 years of life is associated with higher blood pressure and insulin resistance without increased adiposity in childhood: the GUSTO cohort study. Int J Epidemiol. 2020 Oct 1;49(5):1591-1603. doi: 10.1093/ije/dyaa143.
PMID: 32851407BACKGROUNDWaynforth D. Effects of Conception Using Assisted Reproductive Technologies on Infant Health and Development: An Evolutionary Perspective and Analysis Using UK Millennium Cohort Data. Yale J Biol Med. 2018 Sep 21;91(3):225-235. eCollection 2018 Sep.
PMID: 30258309BACKGROUNDZheng W, Yang C, Yang S, Sun S, Mu M, Rao M, Zu R, Yan J, Ren B, Yang R, Guan Y. Obstetric and neonatal outcomes of pregnancies resulting from preimplantation genetic testing: a systematic review and meta-analysis. Hum Reprod Update. 2021 Oct 18;27(6):989-1012. doi: 10.1093/humupd/dmab027.
PMID: 34473268BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
ENRICO PAPALEO, MD
IRCCS San Raffaele
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 18, 2025
First Posted
January 20, 2026
Study Start
December 22, 2025
Primary Completion (Estimated)
October 27, 2028
Study Completion (Estimated)
October 27, 2028
Last Updated
January 20, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share